Dali-on, Pablo G.

HRN: 22-25-83  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/29/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
11/29/2022
12/05/2022
IV
500 Mg
Q8H
Intestinal Amoebiasis
Waiting Final Action 
11/29/2022
CIPROFLOXACIN 500MG (TAB)
11/29/2022
12/06/2022
PO
500mg
BID
Infectious Diarrhea, UTI
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: